Background: There are limited data about the results of simultaneous coronary revascularization, either with coronary artery bypass grafting (CABG) surgery or percutaneous coronary intervention (PCI), and cholecystectomy operations. Here we present clinical outcomes of the patients who underwent simultaneous laparoscopic cholecystectomy (LC) and coronary revascularization at the same session.
INTRODUCTION
Cholelithiasis can be detected in patients with coronary artery disease (CAD) requiring revascularization. Fatal myocardial ischemia has been previously reported in a patient who underwent cholecystectomy by Lee et al [Lee 2010 ]. The rate of symptomatic acute cholelithiasis with the cholecystectomy indication has been reported in 0.5%-0.7% of CAD patients [Alvino 2017 ]. Unfortunately, there are inadequate data about simultaneous cholecystectomy and coronary revascularization. In addition, to our knowledge there is no report about simultaneous cholecystectomy in the early period after the percutaneous coronary intervention (PCI) in patients with cholelithiasis or choledocholithiasis. In limited clinical experiences, Kioke et al and Hekmet et al showed that the risk of myocardial infarction during an abdominal surgery might be reduced after the coronary artery bypass grafting (CABG) operation [Koike 1991; Hekmat 2005] . Treatment of cholecystitis may be performed in an elective or semi-elective situation after cardiac surgery. Because there is a limited amount of scientific information in the literature, no common consensus is present about the treatment methods of cholelithiasis in CAD patients [Bilge Erdogan 2017] .
We conducted this study to assess the safety and efficacy of concomitant laparoscopic cholecystectomy (LC) immediately after the CABG and in the early time after the PCI in 2 centers.
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PATIENTS AND METHODS
This study was carried out in accordance with the Declaration of Helsinki guidelines and was approved by the institutional review board in Koc Vakfi American Hospital, Istanbul, Turkey. All patients have given their written informed consent. The study included 19 patients with CAD and abdominal symptoms related to cholelithiasis or choledocholithiasis as confirmed by ultrasonography or abdominal computed tomography (Figures 1 and 2 ) between January 2008 and June 2016. LC was performed in all patients after coronary revascularization.
The mean age of the patients was 53.0 ± 11.6 years (49-72 years). The preoperative characteristics of the patients in both groups are given in Table 1 . LC and CABG were simultaneously performed in group I (11 patients [57.8%] with a mean age of 56 ± 7.8 years [48-71 years) . The CABG operations were performed using a beating heart technique in 4 patients; the PCI was performed using plain old balloon angioplasty (POBA) or drug-eluting stent (DES) ingroup II (8 patients with a mean age of 49 ± 9.8 years [46-72 years] ). In this group, the LC was performed under general anesthesia 2 or 3 days after coronary stenting. The main indications for cholecystectomy were history of gallstone pancreatitis, jaundice, elevated liver enzymes, right hypochondralgia, or a dilated common bile duct. There was only one patient with a history of abdominal surgery because of gastric cancer.
Simultaneous CABG and LC
After a midline sternotomy, the left internal mammary artery (LIMA) and saphenous vein were harvested. Heparin (3 IU/kg) was given, and an extracorporeal circulation (ECC) was instituted via ascending aorta and a single venous cannulation. After aortic cross-clamping, myocardial arrest was provided using an antegrade and a retrograde cold blood cardioplegias. At the end of distal anastomosis, proximal anastomosis was done using an aortic side clamp. We performed coronary revascularization using a beating heart technique using intracoronary shunt in 4 patients. After CABG, heparin effect was neutralized using protamine, and meticulous hemostasis was achieved carefully. After the closure of sternotomy, the LC was performed without any complication. No significant hemodynamic instability was detected during the LC. Hypochondralgia(n) 6 5
Elevated liver enzyme(n) 2 1 *CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention,BMI: body mass index; MI,myocardial infarction. 
PCI and LC
Exclusion criteria were emergent PCI, history of thrombolytic agent infusion, left ventricular ejection fraction <30%, left main coronary artery disease, hematologic disorders, and chronic kidney disease. PCI or POBA were used ( Figure 3 ). The patients were treated with a loading dose of 100 mg aspirin and 300 mg clopidogrel before the procedure, followed by maintenance dual antiplatelet therapy (75 mg clopidogrel and 100 mg ASA, daily).Two or 3 days later, the LC was performed uneventfully.
LC
After a subcostal mini-incision, a minimal amount of carbon dioxide insufflation was performed to inhibit respiratory problems resulting from the diaphragmatic elevation. The LC was performed using the standard method. There was no intra-abdominal or pulmonary complication. A 7-day course of antibiotics was given after the LC. Oral feeding was started the day after extubation. In the PCI group, dual antiplatelet therapy was started on postoperative day 1. The demographic characteristics including preoperative risk factors, surgical data, and the lengths of ICU and hospital stay were recorded for both groups. The operative and postoperative data are summarized in Table 2 .
Statistical Analyses
All statistical analyses were conducted using SPSS, version 18.0 (PASW Statistics for Windows; SPSS Inc., Chicago, IL, USA). Descriptive statistical methods were used to describe the data. Results were presented as mean ± standard deviation for continuous variables and frequency (percentages) for categorical variables. The comparisons between 2 groups were performed using an unpaired t test for continuous variables and Pearson χ 2 test for categorical variables. All tests were 2-sided, and results with a P value <.05 were considered statistically significant.
RESULTS
The complications such as myocardial ischemia, stroke, renal insufficiency, and pulmonary complications did not occur after the operations or PCI. In one patient from the CABG group, the duration of intubation and ICU stay was prolonged because of respiratory failure. The mean duration of associated procedures was 298.9 ± 33.9 minutes in this group. Durations of LC in the CABG and PCI groups were 56.5 ± 15.6 minutes and 51.3 ± 17.6 minutes, respectively (P >.05). The mean intubation duration was 17 ± 9.6 hours and 5.2 ± 9.6 hours after the CABG and PCI, respectively (P = .001). The mean ICU stay time was 3.1 ± 1.4 days in the CABG group and 1.7 ± 0.4 days in the PCI group (P = .0001). The mean duration of hospital stay was 14.2 ± 3.7 days in the CABG group and 7.4 ± 2.2 days in the PCI group (P = .001).
No intra-abdominal complications were seen in either group. We have not detected wound infection in abdominal incision. No electrocardiographic change such as ST elevation or new Q wave was seen in either group. The postoperative course was uneventful.
DISCUSSION
There is no common consensus about the treatment method in patients with cholecystitis who have severe CAD requiring coronary revascularization. The first case of simultaneous LC and CABG was been reported in 1989 by Hoshino et al [Hoshino 1989 ]. In 2002, successful clinical results of concomitant CABG and cholecystectomy were reported in the largest case series (n = 55 patients) by Hirose et al [Hirose 2002 [Hoshino 1989 ]. In accordance with previous publications, simultaneous LC and CABG surgery could be performed in selected patients [Hirose 2002 ; Bilge Erdogan 2017]. Number of vessels 3.4 ± 1.9 2.1 ± 0.9 .034 The Heart Surgery Forum #2018-1900
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Because the gallbladder has an edematous wall that is fragile early on in acute cholecystitis, Charokopos et al and Hekmat and colleagues have suggested the drainage of the gallbladder under local anesthesia and preferred to postpone cholecystectomy to after CABG. Concomitant surgery of LC and CABG may sound aggressive but could be done safely by experienced surgeons, and it may be advantageous for patients to avoid complications of delayed abdominal surgery [Hirose 2002; Hekmat 2005; Charokopos 2007; Bilge Erdogan 2017] .
It is known that gastrointestinal complications including acalculous cholelithiasis may be encountered 5 or 7 days after CABG, presenting with pain and tenderness on the right hypocondrium with or without liver dysfunction [Ohri 1991; Mangi 2005; Charokopos 2007; Yang 2016] . The mortality rate of cholelithiasis or choledocholithiasis was reported as high as 15% to 42% of these patients [Yang 2016; Mangi 2005] . Urgent cholecystectomy may require general anesthesia shortly after CABG, which may lead to life-threatening complications such as intraoperative hypotension or myocardial ischemia. Therefore, simultaneous cholecystectomy and coronary revascularization is believed to save the patient from the additional general anesthesia and abdominal surgery needed for the separate cholecystectomy and from the complications associated with them.
The clinical outcome of the present cases is similar to previous publications, but the present study has one significant difference. To the best of our knowledge, the present study is the first to demonstrate that the LC can safely be performed 2-3 days after the PCI without the cessation of antiplatelets. It is crucial to use dual antiplatelet therapy after coronary stenting for 12 months as recommended in current guidelines, regardless of the type of stent [Perugini 1997 ]. The cessation of clopidogrel and ASA was suggested 5-7 days before abdominal surgical procedures [Levine 2011 ], though some authors suggested that perioperative mortality risk does not differ by cessation of antiplatelets within 7 days preoperatively [Chernoguz 2011; Helft 2016] . There is no randomized controlled clinical trial to clarify this issue, and a consensus is yet to be established in the management of such patients. Thus, some surgeons refuse to operate on these patients because of increased risk of bleeding complication. Recently, Benahmed et al showed that dual antiplatelet therapy was associated with a low risk of bleeding during abdominal surgery and does not seem to be a contraindication for LC [Benahmed 2014 ]. In a randomized prospective clinical trial on this particular patient group, Chernoguz et al reported that they had neither perioperative mortality nor bleeding complication after such a surgical procedure [Chernoguz 2011] . No intra-abdominal bleeding or stent thrombosis was seen in our PCI patients.
There is no adequate data about the clinical outcome of patients with cholecystitis who underwent simultaneous cholecystectomy and the CABG operation. Yang et al suggested using simultaneous cardiac and extracardiac operation in 14 patients, and they have performed concomitant cholecystectomy and CABG in 3 of 14 patients successfully [Yang 2016] . They have reported common bile duct exploration and T-tube drainage in one case. In accordance with the results of previous investigations [Hoshino 1989; Koike 1991; Hirose 2002; Hekmat 2005 [Hoshino 1989; Koike 1991; Hirose 2002; Hekmat 2005; Charokopos 2007 ]. On the other hand, simultaneous surgery may provide some benefits with favorable clinical outcomes in selected patients. Because management of high-risk patients is a difficult dilemma, some authors suggested a percutaneous cholecystostomy as a treatment of choice [Lee 2010 ]. LC, if performed by experienced surgeons, is associated with shorter hospital stay, low morbidity and mortality rate, and a good cosmetic result. Bilge Erdogan et al have reported successful results of simultaneous LC and CABG in a recent publication [Hekmat 2005] . It is really a challenging decision to manage CAD patients who need abdominal surgery at the same session.
Though both 1-stage and 2-stage procedures are possible, there are several arguments for and against both of these treatment strategies. In accordance with our experiences, we suggest simultaneous coronary artery revascularization (CABG or PCI) and cholecystectomy may be performed safely in selected patients by experienced clinics. Because we do not have a large number of patients or any case-control study, we do not suggest concomitant surgery in each patient. A 2-stage procedure means the administration of anesthetic agents twice for the CABG patients, doubles the surgical trauma, and results in a longer overall stay in hospital. Additionally, it duplicates the preoperative stress and postoperative pain and leads to higher costs of treatment.
In our opinion, we need a large number of randomized clinical trials for confirming the procedure of choice for the best clinical outcomes in these patients. The simultaneous operation might be performed in patients with a history of acute attack of chronic cholelithiasis or those who suffer from jaundice with dilated common bile duct and from recurrent pancreatitis with concomitant severe CAD. Performing simultaneous surgeries on patients with both cardiac and cholelithiasis is possible and acceptable considering the in-hospital mortality of 0% as reported by other researchers [Hoshino 1989; Hekmat 2005; Bilge Erdogan 2017] . There were no postoperative cardiac or abdominal events in both groups in the long-term follow-up of our patients.
Conclusion
Although simultaneous LC and coronary revascularization is an aggressive surgical approach, it may provide good prognosis if performed by an experienced team in carefully selected patients. The 3-year survival rate was ≥87%, and the clinical outcome of our limited number of patients was quite favorable. We believe that a complete preoperative evaluation and an accurate estimation of combined perioperative risk should be carried out before treatment planning in order to select the best surgical strategy in these patients. Our study will continue to collect data and summarize the efficacy of the simultaneous cholecystectomy and cardiac surgery.
